These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6883490)

  • 21. Rubella in Umbria (Italy): serological assessment of immunity in adult women and congenital rubella detection after 1978.
    Iorio AM; Greco M; Trabalza N; Cappuccini B; Barboni G; Perocchi F
    Boll Ist Sieroter Milan; 1981; 60(4):278-83. PubMed ID: 7326102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing antibody to rubella virus in sera collected in Denmark.
    Leerhoy J
    Dan Med Bull; 1968 Nov; 15(9):273-6. PubMed ID: 5760255
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of anti-rubella antibodies in women of childbearing age in Poland.
    Wysokiñska T; Janaszek W; Bucholc B; Gorska P; Gniadek G; Slusarczyk J; Rawicz M
    Vaccine; 2004 May; 22(15-16):1899-902. PubMed ID: 15121301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey.
    Gürgöze MK; Yilmaz E; Gödekmerdan A; Akça Z; Doğan Y; Akarsu S; Aygün AD
    Turk J Pediatr; 2006; 48(3):185-8. PubMed ID: 17172059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rubella susceptibility in the childbearing ages in Lincoln, Nebraska.
    Grenier SR; Milhalko D
    Nebr Med J; 1983 Dec; 68(12):382-6. PubMed ID: 6656950
    [No Abstract]   [Full Text] [Related]  

  • 28. Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome.
    Dayan GH; Zimmerman L; Shteinke L; Kasymbekova K; Uzicanin A; Strebel P; Reef S
    J Infect Dis; 2003 May; 187 Suppl 1():S235-40. PubMed ID: 12721919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rubella virus antibodies among girls and women in Poland].
    Imbs D; Rudnicka H; Prus A
    Przegl Epidemiol; 1980; 34(3):241-7. PubMed ID: 7422904
    [No Abstract]   [Full Text] [Related]  

  • 30. Persistence of rubella antibodies following natural infection.
    Dunlevy M
    J Ir Med Assoc; 1974 Mar; 67(5):127-9. PubMed ID: 4815647
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rubella immunity in female adolescents of the Province of Québec, 1976-1977].
    Lavergne B; Frappier-Davignon L; Chagnon A
    Union Med Can; 1981 Dec; 110(12):1056-9. PubMed ID: 7324280
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
    Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
    Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the immunological status of a sample of the female population 3 years after vaccination against rubella].
    Becchi A; Fornero M
    Nuovi Ann Ig Microbiol; 1981; 32(4):247-52. PubMed ID: 7346775
    [No Abstract]   [Full Text] [Related]  

  • 34. Rubella prevention in family practice with RA27/3 vaccine.
    Hansen NH
    J Fam Pract; 1980 Oct; 11(4):537-42. PubMed ID: 7420029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rubella immunity 5, 6 and 7 years after vaccination of previously seronegative girls].
    Zourbas J; Menant MC; Boivin M
    Nouv Presse Med; 1980 Mar; 9(10):713-4. PubMed ID: 7375354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Susceptibility to measles, rubella and parotitis in young adults].
    Bayas JM; Vilella A; Vidal J; Nebot X; Carbó JM; Navarro G; Prat A; Asenjo MA; Salleras L
    Med Clin (Barc); 1996 Apr; 106(15):561-4. PubMed ID: 8656753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella susceptibility. Provisional study in a suburban high school population.
    Berman RW; Schell NB
    N Y State J Med; 1982 Mar; 82(3):388-90. PubMed ID: 6953345
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immune status against measles and rubella among 4 Chilean groups of different ages].
    Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
    Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.